157 related articles for article (PubMed ID: 21090809)
1. Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.
Kiselev E; Dexheimer TS; Pommier Y; Cushman M
J Med Chem; 2010 Dec; 53(24):8716-26. PubMed ID: 21090809
[TBL] [Abstract][Full Text] [Related]
2. Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation.
Kiselev E; Empey N; Agama K; Pommier Y; Cushman M
J Org Chem; 2012 Jun; 77(11):5167-72. PubMed ID: 22587603
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity.
Alonso C; Fuertes M; González M; Rubiales G; Tesauro C; Knudsen BR; Palacios F
Eur J Med Chem; 2016 Jun; 115():179-90. PubMed ID: 27017547
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 1,5-naphthyridines as topoisomerase I inhibitors. A new family of antiproliferative agents.
Alonso C; Fuertes M; González M; Rodríguez-Gascón A; Rubiales G; Palacios F
Curr Top Med Chem; 2014; 14(23):2722-8. PubMed ID: 25515747
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions.
Kardile RA; Sarkate AP; Borude AS; Mane RS; Lokwani DK; Tiwari SV; Azad R; Burra PVLS; Thopate SR
Bioorg Chem; 2021 Oct; 115():105174. PubMed ID: 34314913
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
7. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.
Martín-Encinas E; Rubiales G; Knudssen BR; Palacios F; Alonso C
Eur J Med Chem; 2019 Sep; 178():752-766. PubMed ID: 31229877
[TBL] [Abstract][Full Text] [Related]
8. Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.
Martín-Encinas E; Rubiales G; Knudsen BR; Palacios F; Alonso C
Bioorg Med Chem; 2021 Jun; 40():116177. PubMed ID: 33962152
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.
Elbadawi MM; Eldehna WM; Wang W; Agama KK; Pommier Y; Abe M
Eur J Med Chem; 2021 Apr; 215():113261. PubMed ID: 33631697
[TBL] [Abstract][Full Text] [Related]
10. Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.
Kiselev E; Agama K; Pommier Y; Cushman M
J Med Chem; 2012 Feb; 55(4):1682-97. PubMed ID: 22329436
[TBL] [Abstract][Full Text] [Related]
11. Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors.
Arepalli SK; Lee C; Sim S; Lee K; Jo H; Jun KY; Kwon Y; Kang JS; Jung JK; Lee H
Bioorg Med Chem; 2018 Oct; 26(18):5181-5193. PubMed ID: 30253887
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
Majumdar P; Bathula C; Basu SM; Das SK; Agarwal R; Hati S; Singh A; Sen S; Das BB
Eur J Med Chem; 2015 Sep; 102():540-51. PubMed ID: 26312433
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.
Beck DE; Abdelmalak M; Lv W; Reddy PV; Tender GS; O'Neill E; Agama K; Marchand C; Pommier Y; Cushman M
J Med Chem; 2015 May; 58(9):3997-4015. PubMed ID: 25909279
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.
Beck DE; Lv W; Abdelmalak M; Plescia CB; Agama K; Marchand C; Pommier Y; Cushman M
Bioorg Med Chem; 2016 Apr; 24(7):1469-79. PubMed ID: 26906474
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.
Elsayed MSA; Su Y; Wang P; Sethi T; Agama K; Ravji A; Redon CE; Kiselev E; Horzmann KA; Freeman JL; Pommier Y; Cushman M
J Med Chem; 2017 Jul; 60(13):5364-5376. PubMed ID: 28657311
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282.
Sooryakumar D; Dexheimer TS; Teicher BA; Pommier Y
Mol Cancer Ther; 2011 Aug; 10(8):1490-9. PubMed ID: 21636699
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.
Zhao Q; Xu X; Xie Z; Liu X; You Q; Guo Q; Zhong Y; Li Z
Bioorg Med Chem Lett; 2016 Feb; 26(3):1068-1072. PubMed ID: 26725027
[TBL] [Abstract][Full Text] [Related]
18. 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.
Kiselev E; DeGuire S; Morrell A; Agama K; Dexheimer TS; Pommier Y; Cushman M
J Med Chem; 2011 Sep; 54(17):6106-16. PubMed ID: 21823606
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.
Yu LM; Zhang XR; Li XB; Yang Y; Wei HY; He XX; Gu LQ; Huang ZS; Pommier Y; An LK
Eur J Med Chem; 2015 Aug; 101():525-33. PubMed ID: 26188908
[TBL] [Abstract][Full Text] [Related]
20. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]